• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EVI1 通过失调 PU.1 功能损害骨髓生成。

EVI1 Impairs myelopoiesis by deregulation of PU.1 function.

作者信息

Laricchia-Robbio Leopoldo, Premanand Kavitha, Rinaldi Ciro R, Nucifora Giuseppina

机构信息

Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

出版信息

Cancer Res. 2009 Feb 15;69(4):1633-42. doi: 10.1158/0008-5472.CAN-08-2562. Epub 2009 Feb 10.

DOI:10.1158/0008-5472.CAN-08-2562
PMID:19208846
Abstract

EVI1 is an oncogene inappropriately expressed in the bone marrow (BM) of approximately 10% of myelodysplastic syndrome (MDS) patients. This disease is characterized by severe anemia and multilineage myeloid dysplasia that are thought to be a major cause of mortality in MDS patients. We earlier reported on a mouse model that constitutive expression of EVI1 in the BM led to fatal anemia and myeloid dysplasia, as observed in MDS patients, and we subsequently showed that EVI1 interaction with GATA1 blocks proper erythropoiesis. Whereas this interaction could provide the basis for the erythroid defects in EVI1-positive MDS, it does not explain the alteration of myeloid differentiation. Here, we have examined the expression of several genes activated during terminal myelopoiesis in BM cells and identified a group of them that are altered by EVI1. A common feature of these genes is their regulation by the transcription factor PU.1. We report here that EVI1 interacts with PU.1 and represses the PU.1-dependent activation of a myeloid promoter. EVI1 does not seem to inhibit PU.1 binding to DNA, but rather to block its association with the coactivator c-Jun. After mapping the PU.1-EVI1 interaction sites, we show that an EVI1 point mutant, unable to bind PU.1, restores the activation of PU.1-regulated genes and allows a normal differentiation of BM progenitors in vitro.

摘要

EVI1是一种癌基因,在约10%的骨髓增生异常综合征(MDS)患者的骨髓(BM)中异常表达。这种疾病的特征是严重贫血和多系髓系发育异常,被认为是MDS患者死亡的主要原因。我们之前报道了一个小鼠模型,在该模型中,BM中EVI1的组成型表达导致了如MDS患者中所观察到的致命性贫血和髓系发育异常,随后我们发现EVI1与GATA1的相互作用会阻碍正常的红细胞生成。虽然这种相互作用可能为EVI1阳性MDS中的红系缺陷提供了基础,但它并不能解释髓系分化的改变。在这里,我们检测了BM细胞终末髓系生成过程中几个被激活基因的表达,并鉴定出其中一组基因被EVI1改变。这些基因的一个共同特征是它们受转录因子PU.1的调控。我们在此报告,EVI1与PU.1相互作用并抑制髓系启动子的PU.1依赖性激活。EVI1似乎并不抑制PU.1与DNA的结合,而是阻断其与共激活因子c-Jun的结合。在定位了PU.1-EVI1相互作用位点后,我们表明一个无法结合PU.1的EVI1点突变体可恢复PU.1调控基因的激活,并使BM祖细胞在体外正常分化。

相似文献

1
EVI1 Impairs myelopoiesis by deregulation of PU.1 function.EVI1 通过失调 PU.1 功能损害骨髓生成。
Cancer Res. 2009 Feb 15;69(4):1633-42. doi: 10.1158/0008-5472.CAN-08-2562. Epub 2009 Feb 10.
2
EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.EVI1招募组蛋白甲基转移酶SUV39H1以抑制转录。
J Cell Biochem. 2008 Oct 1;105(2):344-52. doi: 10.1002/jcb.21869.
3
Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.EVI1致癌基因的逆转录病毒插入激活并不阻止粒细胞集落刺激因子诱导的小鼠多能髓系细胞系32Dcl3的成熟。
Oncogene. 1996 Feb 1;12(3):563-9.
4
Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.EVI1介导的miRNA-124甲基化与沉默及小鼠骨髓增生异常综合征中造血干细胞的自我更新耗竭
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9783-8. doi: 10.1073/pnas.1004297107. Epub 2010 May 6.
5
Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.EVI1两个锌指结构域中的点突变消除了EVI1与GATA1的相互作用,并使小鼠骨髓细胞发生红系分化。
Mol Cell Biol. 2006 Oct;26(20):7658-66. doi: 10.1128/MCB.00363-06. Epub 2006 Sep 5.
6
Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.髓系转化蛋白Evi1与甲基化CpG结合域蛋白3相互作用,并在体外抑制Mbd3/Mi-2/NuRD介导的组蛋白去乙酰化作用。
Biochemistry. 2008 Jun 17;47(24):6418-26. doi: 10.1021/bi800267f. Epub 2008 May 24.
7
A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.原癌基因Evi1与组蛋白甲基转移酶SUV39H1和G9a之间的新型相互作用。
FEBS Lett. 2008 Aug 6;582(18):2761-7. doi: 10.1016/j.febslet.2008.06.056. Epub 2008 Jul 11.
8
Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.小鼠巨噬细胞与B淋巴细胞中转录因子PU.1(Spi-1原癌基因)的表达及功能比较
Oncogene. 1994 Jan;9(1):121-32.
9
Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.EVI1对RUNX1活性的抑制:EVI1在白血病发生中的新作用。
Cancer Res. 2007 Jun 15;67(12):5658-66. doi: 10.1158/0008-5472.CAN-06-3962.
10
Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.干扰素调节因子4和干扰素共有序列结合蛋白在巨噬细胞中的差异表达及不同功能
J Immunol. 1999 Sep 1;163(5):2713-22.

引用本文的文献

1
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7.PRC2介导的凋亡逃避是伴有inv(3)/t(3;3)和7号染色体单体的骨髓增生异常综合征/急性髓系白血病的一个治疗靶点。
Hemasphere. 2025 Jul 13;9(7):e70149. doi: 10.1002/hem3.70149. eCollection 2025 Jul.
2
Evi1 governs Kdm6b-mediated histone demethylation to regulate the Laptm4b-driven mTOR pathway in hematopoietic progenitor cells.Evi1调控Kdm6b介导的组蛋白去甲基化,以调节造血祖细胞中Laptm4b驱动的mTOR信号通路。
J Clin Invest. 2024 Dec 16;134(24):e173403. doi: 10.1172/JCI173403.
3
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
靶向 AML 中 3q26 病变和 EVI1 过表达的表观遗传机制的临床前疗效。
Leukemia. 2024 Mar;38(3):545-556. doi: 10.1038/s41375-023-02108-3. Epub 2023 Dec 12.
4
EVI1-mediated Programming of Normal and Malignant Hematopoiesis.EVI1介导的正常和恶性造血编程。
Hemasphere. 2023 Oct 4;7(10):e959. doi: 10.1097/HS9.0000000000000959. eCollection 2023 Oct.
5
The CSN5/HSF/SPI1/PU.1 Axis Regulates Cell Proliferation in Hypocellular Myelodysplastic Syndrome Patients.CSN5/HSF/SPI1/PU.1轴调节低细胞性骨髓增生异常综合征患者的细胞增殖。
J Pediatr Hematol Oncol. 2023 Oct 1;45(7):e873-e878. doi: 10.1097/MPH.0000000000002712. Epub 2023 Aug 1.
6
Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle.新出现的骨髓衰竭综合征——未解谜题的新碎片。
Front Oncol. 2023 Apr 6;13:1128533. doi: 10.3389/fonc.2023.1128533. eCollection 2023.
7
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development.PU.1-c-Jun 相互作用对于 PU.1 在髓系发育中的功能至关重要。
Commun Biol. 2022 Sep 14;5(1):961. doi: 10.1038/s42003-022-03888-7.
8
Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia.单细胞水平的基因表达:对骨髓增生异常综合征和急性髓系白血病的影响。
Blood. 2021 Aug 26;138(8):625-636. doi: 10.1182/blood.2019004261.
9
NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells.NKL 同源盒基因 VENTX 是人类常规树突状细胞调控网络的一部分。
Int J Mol Sci. 2021 May 31;22(11):5902. doi: 10.3390/ijms22115902.
10
EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.EVI1 失调:对髓系恶性肿瘤的生物学和治疗的影响。
Blood Cancer J. 2021 Mar 22;11(3):64. doi: 10.1038/s41408-021-00457-9.